BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal 2024, which ended March 31, 2024.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ended December 31, 2023.
PerkinElmer, a leading global analytical services and solutions provider, today announced that it has acquired Covaris, a leading developer of solutions to empower life science innovations.
Recognizing the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva has opened its expanded Shanghai facility. The facility is 11 000 m2, fully operational, and designed to help advance and accelerate the development of novel therapeutics. Customers have access to a wide range of technologies, solutions, and services, including Cytiva’s Fast Trak training center, a Center of Excellence for single-use technologies, and a new automation and digital lab. It is also home to China’s online experience center, customized bioprocess solutions labs and compliance validation labs.
Medical tool supplier Danaher (DHR) is expanding its product offerings by purchasing British biotech firm Abcam Plc (ABCM) for $5.7 billion, including debt.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its third quarter of fiscal 2023, which ended June 30, 2023.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2023.
On July 19, Mindray and Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) held a strategic cooperation signing ceremony at Mindray` s headquarters in Shenzhen.
Based on the advantages of their respective fields, the two companies will carry out in-depth cooperation in life information and support, in vitro diagnosis, medical imaging, overall solutions for two cancer screening, hospital department equipment, information construction, etc., and jointly establish the "Hybribio-Mindray Standardized Laboratory" to achieve complementary advantages and resource sharing.
GenScript Biotech, a preeminent global provider of life sciences services, and Boan Biotech, an integrated biopharmaceutical company specializing in the development, manufacturing and commercialization of biologics, announced a collaboration for the development and production of GenCircleTM dsDNA, a small circular double-stranded DNA vector without resistance markers, a key ingredient in gene and cell therapy.
✔ All (13)
✔ Press release (0)
✔ Industry news (13)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.